<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">
cancercantwait-grn

Experts are predicting that delays to lung cancer diagnosis and treatment during the COVID-19 pandemic will lead to increased mortality in coming years.

WEBINAR REPLAY
dr-o-webinar-2replayu

Advances in the early detection and treatment of lung cancer have led to significant improvements in prognosis and survival in recent years. The COVID-19 pandemic has created an unprecedented environment that threatens to diminish that progress.

In this webinar presentation, three lung cancer experts discussed balancing COVID-19 exposure risk from diagnostic procedures with the pursuit of early diagnosis of lung cancer. Topics covered include COVID-19 policies and guidelines that impact detection and diagnosis, improvement of early detection, time to diagnosis and treatment, and how telemedicine and blood-based lung nodule testing can address the need for improved nodule classification and early diagnosis during the COVID-19 pandemic.

Watch the Replay

Even during a global pandemic, Cancer Can’t Wait. Blood-based testing delivers critical information needed to help detect lung cancer early and treat patients quickly while limiting exposure risk from in-person appointments.

Blood-based lung nodule test helps prioritize patients for diagnostic intervention

nodifylung-654

drop-orange

 
  • Helps identify patients with a high risk of malignancy that may benefit from timely intervention
  • Helps reduce patient anxiety associated with watchful waiting

LEARN MORE

Blood-based testing expedites time to treatment with molecular results in 72 hours

bdx-lung-logo

green-drop

 
  • Actionable molecular results to help identify patients with a sensitizing mutation who may benefit from oral therapy.
  • Measurement of patient’s immune response to support personalized treatment decisions

LEARN MORE


Clinical practice is changing. Incorporate Nodify Lung™ testing or Biodesix Lung Reflex® into your practice today.

 

We coordinate blood draws through our network of certified mobile phlebotomists. Just submit an order in the Biodesix Physician Portal or submit a signed Test Request Form (TRF).

phone-img

PORTAL SIGN UP

 forms-img

DOWNLOAD TRF

NodifyLung Remote Ordering

Watch this short video to learn how easy it is to order Nodify Lung blood-based lung nodule testing using the Biodesix Physician Portal and Mobile Phlebotomy services.

Use telemedicine appointments to drive shared-decision making and limit office visits

nodifylung-654

Discuss the diagnostic plan for a new lung nodule
Biodesix Lung Color Logo

Inform treatment options and timing following a new lung cancer diagnosis

Resources to learn more about the impact of COVID-19 on cancer care

Get in Touch

Contact Us

Data Library

Discover More

References:

51% of practices are limiting the use of biopsies and other screening methods during the COVID-19 pandemic1,2

49% of practices are experiencing delays in receiving molecular testing results during the COVID-19 pandemic1,2

90% of practices are implementing virtual office visits during the COVID-19 pandemic1,2

5% expected increase in lung cancer related deaths over next 5 years due to lack of access and availability to diagnostic services during the COVID-19 pandemic3,4

38% decrease in new lung cancer diagnoses during the COVID-19 pandemic.5

  1. Healthcare Research & Analytics. COVID-19 Impact on Oncology. https://www.hraresearch.com/covid-19-impact-on-oncology/
  2. Myshko, Denise. COVID-19 Is Expected to Have Long-term Impact on Oncology Practices. OncLive. Published Online June 25, 2020.
  3. Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. The Lancet Oncology. Published Online July 20, 2020.
  4. Sharpless, Norman. COVID-19 and cancer. Science. 2020; 368(6497): 1290.

  5. Kaufman H, Chen Z, Niles J, et al. Changes in the Number of US Patients with Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. JAMA Network. 2020; 3(8): e2017267. “Decrease in new cancer diagnoses before and during the COVID-19 pandemic”